Search for a research project
Other search option(s)
34 Result(s)
Terminated research projects = 
Funded by an IRDiRC member = 
Study involving ERN members in at least two Member States = 
Research projects
FINLAND
Finland
OULU
Bullous pemphigoid: predisposing factors and mechanisms of autoimmunization
University of Oulu
Biocenter Oulu
FRANCE
ILE-DE-FRANCE
PARIS
RaDiCo-FARD: National Cohort for Evaluation of the Burden of Rare Skin Diseases
Institut National de la Santé et de la Recherche Médicale
FRANCE
NORMANDIE
ROUEN
Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid
CHU de Rouen
Centre de Référence Maladies Bulleuses Auto-immunes
FRANCE
NORMANDIE
ROUEN
Study of B clone specific of Desmogleines and antigens of bullous pemphigoid
Faculté de médecine et de pharmacie de Rouen
Physiopathologie et biothérapies des maladies inflammatoires et auto-immunes
FRANCE
NORMANDIE
ROUEN
Study of genetic factors leading to appearance of pemphigus vulgaris, foliaceous and paraneoplastic
Faculté de médecine et de pharmacie de Rouen
Physiopathologie et biothérapies des maladies inflammatoires et auto-immunes
FRANCE
NORMANDIE
ROUEN
Animal and experimental models of pemphigus vulgaris, foliaceous and paraneoplastic
Faculté de médecine et de pharmacie de Rouen
Physiopathologie et biothérapies des maladies inflammatoires et auto-immunes
GERMANY
Baden-Württemberg
FREIBURG
PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): Autoimmunity against desmocollins in pemphigus (SP6)
Universitäts-Klinik für Dermatologie und Venerologie
Klinik für Dermatologie und Venerologie
GERMANY
Baden-Württemberg
HEIDELBERG
Comparison of the therapeutic response of patients with BP180-reactive bullous pemphigoid (BP) and patients with BP230-reactive BP
Universitäts-Hautklinik Heidelberg
Hautklinik
GERMANY
Baden-Württemberg
TÜBINGEN
PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): T-cell-dependent regulation of autoreactive B cells in pemphigus (SP2)
Universitäts-Hautklinik
GERMANY
Bayern
MÜNCHEN
PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): Desmoglein-dependent signaling complexes in pemphigus (SP5)
Anatomische Anstalt der LMU München
Anatomische Anstalt - Lehrstuhl I
GERMANY
Hessen
GIEßEN
PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): Flotillins in the regulation of desmosomal adhesion in pemphigus (SP4)
Justus-Liebig-Universität Gießen
Institut für Biochemie - AG Prof. Dr. A. Bindereif
GERMANY
Hessen
MARBURG
PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): Human leukocyte antigen (HLA)-transgenic mice as a pre-clinical model of pemphigus vulgaris (SP1)
BPC - Philipps Universität Marburg
Biochemical Pharmacological Center (BPC)
GERMANY
Hessen
MARBURG
PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): T-cell-dependent regulation of autoreactive B cells in pemphigus (SP2)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Allergie-Zentrum Hessen / Klinik für Dermatologie und Allergologie
GERMANY
Niedersachsen
GÖTTINGEN
KFO 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential
Institut für Humangenetik der Universität Göttingen
Institut für Humangenetik
GERMANY
Nordrhein-Westfalen
AACHEN
FullSkin: Evaluation of a new test system for diagnosis and therapy planning of severe blistering autoimmune diseases of the skin
Universitätsklinikum Aachen
Klinik für Dermatologie und Allergologie
GERMANY
Nordrhein-Westfalen
AACHEN
FullSkin: Evaluation of a new test system for diagnosis and therapy planning of severe blistering autoimmune diseases of the skin
Universitätsklinikum Aachen
GERMANY
Schleswig-Holstein
LÜBECK
Bispecific antibodies for the treatment of the autoimmune disease epidermolysis bullosa acquisita
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Klinik für Dermatologie, Allergologie und Venerologie
GERMANY
Schleswig-Holstein
LÜBECK
KFO 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Klinik für Dermatologie, Allergologie und Venerologie
GERMANY
Schleswig-Holstein
LÜBECK
The role of complement in mucous membrane pemphigoid
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Klinik für Dermatologie, Allergologie und Venerologie
GERMANY
Schleswig-Holstein
LÜBECK
LiBPem-Study: Adjuvant therapy of severe and / or refractory bullous pemphigoids with immune adsorption using LigaSorb®, dapsone, prednisolone and topical mometasone furoate
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Klinik für Dermatologie, Allergologie und Venerologie
GERMANY
Schleswig-Holstein
LÜBECK
DPem : Dimethylfumarate for the treatment of bullous pemphigoid -DE-
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Lübecker Institut für Experimentelle Dermatologie
GERMANY
Schleswig-Holstein
LÜBECK
KFO 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Lübecker Institut für Experimentelle Dermatologie
GERMANY
Schleswig-Holstein
LÜBECK
The role of complement in mucous membrane pemphigoid
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Lübecker Institut für Experimentelle Dermatologie
JAPAN
JAPAN
TOKYO
Investigators initiated clinical trial of rituximab for steroid treatment-resistant pemphigus
Keio University School of Medicine
Department of Dermatology
SWITZERLAND
Suisse Alémanique
BERN
PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): Epitope spreading in Pemphigus (SP7)
Universitätsspital Inselspital
Universitätsklinik für Dermatologie
UNITED KINGDOM
Leicestershire
LEICESTER
Antibody Profiles in Inflammatory and Non-Inflammatory Bullous Pemphigoid
Leicester Univ. Hosp. NHS - Leicester Royal Infirmary
Dermatology Department
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Engineering disease-specific t cells for pemphigus therapy
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Structure and mechanism of pemphigus autoantibodies
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Improving Clinical Trial Recruitment and Outcome Measures in Bullous Pemphigoid
Institution: Information not provided - US
FRANCE
ILE-DE-FRANCE
PARIS
Rho GTPases and rare skin diseases
IMAGINE - Institut des Maladies Génétiques
Institut IMAGINE - INSERM U1163
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
The ige antibody response to dsg1 and environmental antigens in endemic pemphigus foliaceus
Institution: Information not provided - US
Multicentric Research projects
- Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
- Klinik für Dermatologie und Allergologie
- Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
- Klinik für Dermatologie und Allergologie
- Universitätsklinikum Schleswig-Holstein - Campus Lübeck
- Lübecker Institut für Experimentelle Dermatologie
GERMANY
Hessen
MARBURG
PEMPHIGUS: Von der Autoimmunität zur Krankheit
GERMANY
Hessen
MARBURG
PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497)
GERMANY
Schleswig-Holstein
LÜBECK